• 1. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Fumonisins

Fumonisin B1-13C4 (CAS No. 1324564-22-8): A Comprehensive Overview

Fumonisin B1-13C4 (CAS No. 1324564-22-8) is a labeled derivative of Fumonisin B1, a mycotoxin produced by Fusarium fungi, particularly Fusarium verticillioides and Fusarium proliferatum. This compound is of significant interest in the fields of food safety, toxicology, and pharmaceutical research due to its potential health impacts and its role in understanding the mechanisms of mycotoxin toxicity.

Fumonisin B1 is a naturally occurring mycotoxin that primarily contaminates maize and other cereal grains. It is known for its ability to cause various health issues in both humans and animals, including liver damage, kidney toxicity, and neurotoxic effects. The labeled form, Fumonisin B1-13C4, is used in research to trace the metabolism and distribution of this toxin in biological systems, providing valuable insights into its mechanisms of action.

The chemical structure of Fumonisin B1-13C4 is characterized by a long hydrocarbon chain with multiple hydroxyl groups and a unique tricarballylic acid moiety. The incorporation of four carbon-13 isotopes (denoted as -13C4) allows for precise quantification and tracking of the compound using advanced analytical techniques such as mass spectrometry. This labeling technique enhances the accuracy and reliability of research findings, making it an essential tool in the study of mycotoxin metabolism.

Recent studies have highlighted the importance of Fumonisin B1-13C4 in elucidating the molecular mechanisms underlying its toxic effects. For instance, research published in the Journal of Agricultural and Food Chemistry has shown that Fumonisin B1 can disrupt sphingolipid metabolism, leading to cellular dysfunction and apoptosis. The use of labeled compounds like Fumonisin B1-13C4 has enabled researchers to track these metabolic changes in real-time, providing a deeper understanding of the toxin's mode of action.

In addition to its role in basic research, Fumonisin B1-13C4 is also valuable in the development of diagnostic tools and therapeutic strategies. By accurately quantifying the levels of this toxin in biological samples, researchers can assess exposure risks and develop methods to mitigate its harmful effects. This is particularly important in regions where maize consumption is high, as these areas are more susceptible to fumonisin contamination.

The application of Fumonisin B1-13C4 extends beyond food safety and toxicology. In pharmaceutical research, this compound is used to study the potential interactions between mycotoxins and other environmental toxins, as well as their combined effects on human health. For example, a study published in Toxicological Sciences investigated the synergistic toxicity of Fumonisin B1 with other common mycotoxins such as aflatoxin and ochratoxin A. The results indicated that co-exposure to these toxins can significantly exacerbate their individual toxic effects, highlighting the need for comprehensive risk assessment strategies.

The use of labeled compounds like Fumonisin B1-13C4 also plays a crucial role in regulatory compliance. Regulatory agencies such as the Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) rely on accurate data to set safe exposure limits for mycotoxins in food products. The precision provided by labeled compounds ensures that these limits are based on robust scientific evidence, thereby protecting public health.

In conclusion, Fumonisin B1-13C4 (CAS No. 1324564-22-8) is a vital tool in the study of mycotoxin toxicity and metabolism. Its unique properties make it an indispensable resource for researchers working in food safety, toxicology, and pharmaceutical development. By continuing to advance our understanding of this compound, we can develop more effective strategies to mitigate its harmful effects and ensure the safety and quality of our food supply.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)